Cargando…
Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real‐world study
BACKGROUND: The aim of this study was to analyze the effectiveness and safety of H101 in Chinese patients with malignant pleural effusion and ascites (MPE/MA) in the real world. METHODS: This multicenter, observational, real‐world study recruited patients with MPE/MA caused by malignant tumor receiv...
Autores principales: | Wang, Baocheng, Zhong, Chen, Liao, Zijun, Wang, Haitao, Cai, Xiuyu, Zhang, Yanbing, Wang, Jun, Wang, Tianxiao, Yao, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599969/ https://www.ncbi.nlm.nih.gov/pubmed/37675621 http://dx.doi.org/10.1111/1759-7714.15101 |
Ejemplares similares
-
Quality assessment of the guidelines for the management of malignant pleural effusions and ascites
por: Li, Jia-Xi, et al.
Publicado: (2020) -
Efficacy of Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural or Peritoneal Effusions
por: ZHANG, Xin, et al.
Publicado: (2013) -
Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023) -
Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022) -
Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
por: Biaoxue, Rong, et al.
Publicado: (2016)